AI Turns Vulnerability Management Into a Throughput Problem 
Neutrik® Connects Made-To-Order, High-Performance AV Solutions For RCI Custom 
AceDraft Announces AceDraft, a Free ATS Resume Tool to Help Gen Z Job Seekers Match Job Descriptions 
uSMART Becomes the World’s First Technology Brokerage to Offer Both ‘Night and Pre-Market Trading’ in U.S. Options 
Chervon Names Doug Palmer Vice President of Finance – Canada What Coaching Can Do for Anyone With Money Troubles – And How It Gets It Done
NEW YORK, NY / ACCESSWIRE / December 24, 2021 / There aren’t many subjects more…
FDA Authorizes Marketing of 22nd Century Group’s VLN® as a Modified Risk Tobacco Product
VLN® Cigarettes VLN® King & VLN® Menthol King VLN® Is World’s First and Only Combustible…
Sosei Heptares Announces Antitrust Clearance of License Agreement with Neurocrine Biosciences
TOKYO, Japan and CAMBRIDGE, United Kingdom, Dec. 23, 2021 (GLOBE NEWSWIRE) — Sosei Group Corporation…
Vaxxinity Reports Third Quarter 2021 Financial Results and Provides Corporate Updates
DALLAS, Dec. 23, 2021 (GLOBE NEWSWIRE) — Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering…
Aeterna Zentaris Appoints Giuliano La Fratta as Chief Financial Officer
– Well-established finance professional with over 20 years of experience gained in pharmaceutical, biopharma and…
PDS Biotech Reports An Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
FLORHAM PARK, N.J., Dec. 23, 2021 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a…
FDA Authorizes Marketing of 22nd Century Group’s VLN® as a Modified Risk Tobacco Product
VLN® Cigarettes VLN® King & VLN® Menthol King VLN® Is World’s First and Only Combustible…
Valneva and Scottish Enterprise in Advanced Discussions for Major Grant to Complete Livingston Site
Saint Herblain (France), December 23, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a…
Cassava Sciences Launches Clinical Website to Support Phase 3 Studies of Oral Simufilam in Alzheimer’s Disease
New website (www.Rethink-ALZ.com) is intended to increase visibility and information for potential study participants. Rethink-ALZ.com…
Radius Announces Update on TYMLOS® (abaloparatide) Label
FDA approved the removal of the boxed warning from the TYMLOS label, effective December 22,…
Vallon Pharmaceuticals Announces Achievement of Last Patient Last Visit in Pivotal SEAL Study for Lead Program, ADAIR
– Topline results from pivotal SEAL study expected in Q1 2022 – If approved, ADAIR…
Codex DNA Expands Catalog of COVID-19 Tools with Release of Full-Length Synthetic Genome for SARS-CoV-2 Omicron Variant
Researchers around the world can utilize the synthetic genome to produce virus to test strain-specific…
Arcutis Biotherapeutics Secures $225 Million in Non-Dilutive Debt Financing from SLR Capital Partners
WESTLAKE VILLAGE, Calif., Dec. 23, 2021 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage…
CENTOGENE Wins Award in Digital Healthcare Innovation for Artificial Intelligence (AI) Platform Leading Biomarker Discovery
Leveraging AI to Accelerate the Path From Diagnosis to Cure CAMBRIDGE, Mass. and ROSTOCK, Germany…
Todos Medical CEO to Appear on Yahoo Finance Live! at 12:10PM EST with Akiko Fujita to Talk Pfizer’s Paxlovid Approval, Tollovir™ Phase 2 & COVID Testing
CEO Gerald Commissiong is also scheduled to appear on BNC at 1:50PM EST to discuss…
XOMA Declares Quarterly Preferred Stock Dividends
EMERYVILLE, Calif., Dec. 23, 2021 (GLOBE NEWSWIRE) — XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the…
Cyclacel Pharmaceuticals to Participate in Biotech Showcase 2022 Virtual Conference
BERKELEY HEIGHTS, N.J., Dec. 23, 2021 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ:…
IBEX Announces Stock Option Grant to Directors and Employees
MONTREAL, Dec. 23, 2021 (GLOBE NEWSWIRE) — IBEX Technologies Inc. (TSX Venture: IBT), today announced…
Bridgeline Inks New Deal with Leading Promotional Product Seller
WOBURN, Mass., Dec. 23, 2021 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), a cloud-based…
Nubeva Announces Third-Party Validation Of Its Upcoming Ransomware Reversal Solution
Extended Third-Party Testing Confirms Software is Effective For 96% of Ransomware Tested SAN JOSE, Calif.,…